Providing TaSP When Stuck Between a Rock & a Hard Place
In the absence of universal antiretroviral (ARV) treatment, should we prioritize on providing HIV meds to the main drivers of the epidemic first before making them available to the rest of the population? This new theory from aidsmap says yes.
If countries followed the idea, it would mean injection drug users and female sex workers would be treated before all other at-risk groups.
POZ Exclusive: Jetsons-Era HIV Care and Prevention
Let’s take a quick look over some futuristic highlights from this year’s Conference on Retroviruses and Opportunistic Infections (CROI):
David Duran: “In a perfect world, everyone would get tested, know their status, and take the appropriate steps thereafter…
Having an undetectable viral load would be sexy. Knowing your status and getting tested regularly would be, well, regular. Being HIV positive and having an undetectable viral load would be considered the same thing as being HIV negative.”
Thinking TasP: Does Treatment as Prevention Really Care for the HIV-Positive?
Health professor, Perry Halkitis questions whether or not TasP is yet another another approach that aims to place the responsibility of the epidemic entirely on the shoulders of HIV+ people.
Can There Be a Fourth Great Wave of AIDS Activism?
Raymond Smith writes:
"The major new opportunity that has arisen recently has been encapsulated in the term "treatment as prevention." Powerful new evidence has emerged that ARVs not only can preserve the lives and the health of people with HIV but, by lowering their viral load, can significantly reduce the odds of new transmissions….
Talk of ‘the end of AIDS’ has begun to feel, for the first time, like an attainable reality—but only if HIV/AIDS once again receives enough focus and energy.”
Navigating Treatment as Prevention
From our latest issue. People with HIV who take antiretrovirals may lower their chance of spreading the virus by 96 percent. Or is it 26 (or even 100)? Trenton Straube breaks it down.
The April/May Issue of POZ is out online!
Featuring: Overcoming substance abuse with HIV, Navigating Treatment as Prevention, & more.
Achieving the EndThe executive director of AVAC, a global advocacy group for biomedical HIV prevention, outlines five major priorities for action in 2013 in our March issue.
Uganda Study Adds to Growing Proof of Treatment as Prevention’s Success
A study of serodiscordant heterosexual couples in Uganda has found that the HIV-positive partner never transmitted the virus to the other if he or she was taking antiretrovirals (ARVs).
To read more, click here.
Treatment as Prevention: Not as Simple as It Sounds
For many of us, the concerns about “treatment as prevention” (using drugs before or after exposure to HIV to prevent infection by the virus as opposed to using drugs after infection to stop it from progressing) isn’t about whether or not it is effective on an individual basis in preventing HIV transmission. It is.
Read more of Sean Strub’s blog : http://blogs.poz.com/sean/archives/2012/11/treatment_as_prevention.html